Clinical Trial of Autologous CD19 CAR-T Cells (CNCT19) Therapy for Advanced Hepatocellular Carcinoma
NCT06676982
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Advanced Hepatocellular Carcinoma
Interventions
BIOLOGICAL:
anti-CD19 CAR-T
Sponsor
Zhejiang University
Collaborators
[object Object]